{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:25:39Z","timestamp":1762431939839},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Primary open-angle glaucoma (POAG) is a progressive neurodegenerative disease which leads to irreversible blindness. An elevated intraocular pressure (IOP) is considered to be the main risk factor for the disease progression. It is known that retinal blood flow is altered in POAG eyes. Tafluprost, a prostaglandin analogue which lowers the IOP, has shown to also improve the retinal blood flow in animals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The current study therefore evaluated the retinal vessel density in the peripapillary and macular region of POAG patients with normal IOP treated with topical Tafluprost (<jats:italic>n<\/jats:italic>\u00a0=\u200920) compared to surgically treated patients with normal IOP (<jats:italic>n<\/jats:italic>\u00a0=\u200922) using optical coherence tomography angiography (OCT-A). The retinal flow density was obtained after binarisation and evaluated in five sectors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a significantly higher peripapillary flow density in all sectors in Tafluprost treated eyes when compared to post-surgery eyes. The flow density in the inferior sector of the superficial plexus in the macular region was also significantly higher in the Tafluprost group.<\/jats:p><jats:p>Conclusions: These results indicate that Tafluprost not only lowers IOP, but may also enhance retinal blood flow in POAG patients with a normal IOP.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12886-020-01707-3","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T13:03:02Z","timestamp":1605186182000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Hannah","family":"Weindler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Schulthei\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"issue":"18","key":"1707_CR1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901\u201311.","journal-title":"JAMA."},{"issue":"5","key":"1707_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bjo.80.5.389","volume":"80","author":"HA Quigley","year":"1996","unstructured":"Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389\u201393.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1707_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2016-000032","volume":"1","author":"KKW Chan","year":"2017","unstructured":"Chan KKW, Tang F, Tham CCY, Young AL, Cheung CY. Retinal vasculature in glaucoma: a review. BMJ Open Ophthalmol. 2017;1(1):e000032.","journal-title":"BMJ Open Ophthalmol"},{"issue":"13","key":"1707_CR4","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.1167\/iovs.17-22865","volume":"58","author":"G Triolo","year":"2017","unstructured":"Triolo G, Rabiolo A, Shemonski ND, Fard A, Di Matteo F, Sacconi R, et al. Optical coherence tomography angiography macular and Peripapillary vessel perfusion density in healthy subjects, glaucoma suspects, and glaucoma patients. Invest Ophthalmol Vis Sci. 2017;58(13):5713\u201322.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 2","key":"1707_CR5","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/j.survophthal.2007.08.012","volume":"52","author":"J Flammer","year":"2007","unstructured":"Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52(Suppl 2):S162\u201373.","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"1707_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/jop.2007.0065","volume":"24","author":"N Izumi","year":"2008","unstructured":"Izumi N, Nagaoka T, Sato E, Mori F, Takahashi A, Sogawa K, et al. Short-term effects of topical tafluprost on retinal blood flow in cats. J Ocul Pharmacol Ther. 2008;24(5):521\u20136.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"1707_CR7","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1167\/iovs.10-5218","volume":"51","author":"C Mayama","year":"2010","unstructured":"Mayama C, Ishii K, Saeki T, Ota T, Tomidokoro A, Araie M. Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma. Invest Ophthalmol Vis Sci. 2010;51(8):4117\u201324.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"1707_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188692","volume":"12","author":"N Aizawa","year":"2017","unstructured":"Aizawa N, Kunikata H, Shiga Y, Tsuda S, Yokoyama Y, Omodaka K, et al. Preperimetric glaucoma prospective observational study (PPGPS): design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye. PLoS One. 2017;12(12):e0188692.","journal-title":"PLoS One"},{"issue":"1","key":"1707_CR9","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1038\/s41598-017-05258-4","volume":"7","author":"Y Iida","year":"2017","unstructured":"Iida Y, Akagi T, Nakanishi H, Ohashi Ikeda H, Morooka S, Suda K, et al. Retinal blood flow velocity change in Parafoveal capillary after topical Tafluprost treatment in eyes with primary open-angle glaucoma. Sci Rep. 2017;7(1):5019.","journal-title":"Sci Rep"},{"issue":"9","key":"1707_CR10","doi-asserted-by":"publisher","first-page":"OCT27","DOI":"10.1167\/iovs.15-19043","volume":"57","author":"SS Gao","year":"2016","unstructured":"Gao SS, Jia Y, Zhang M, Su JP, Liu G, Hwang TS, et al. Optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(9):OCT27\u201336.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1707_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/17434440.2016.1230014","volume":"13","author":"K Mansouri","year":"2016","unstructured":"Mansouri K. Optical coherence tomography angiography and glaucoma: searching for the missing link. Expert Rev Med Devices. 2016;13(10):879\u201380.","journal-title":"Expert Rev Med Devices"},{"issue":"9","key":"1707_CR12","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1167\/iovs.17-21846","volume":"58","author":"HS Chen","year":"2017","unstructured":"Chen HS, Liu CH, Wu WC, Tseng HJ, Lee YS. Optical coherence tomography angiography of the superficial microvasculature in the macular and Peripapillary areas in glaucomatous and healthy eyes. Invest Ophthalmol Vis Sci. 2017;58(9):3637\u201345.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1707_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.sjopt.2018.09.006","volume":"32","author":"T Mansoori","year":"2018","unstructured":"Mansoori T, Gamalapati J, Sivaswamy J, Balakrishna N. Optical coherence tomography angiography measured capillary density in the normal and glaucoma eyes. Saudi J Ophthalmol. 2018;32(4):295\u2013302.","journal-title":"Saudi J Ophthalmol"},{"issue":"5","key":"1707_CR14","first-page":"835","volume":"11","author":"C Lommatzsch","year":"2018","unstructured":"Lommatzsch C, Rothaus K, Koch JM, Heinz C, Grisanti S. Vessel density in OCT angiography permits differentiation between normal and glaucomatous optic nerve heads. Int J Ophthalmol. 2018;11(5):835\u201343.","journal-title":"Int J Ophthalmol"},{"key":"1707_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ajo.2017.07.011","volume":"182","author":"T Shoji","year":"2017","unstructured":"Shoji T, Zangwill LM, Akagi T, Saunders LJ, Yarmohammadi A, Manalastas PIC, et al. Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study. Am J Ophthalmol. 2017;182:107\u201317.","journal-title":"Am J Ophthalmol"},{"key":"1707_CR16","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.12688\/f1000research.11691.1","volume":"6","author":"KH Wan","year":"2017","unstructured":"Wan KH, Leung CKS. Optical coherence tomography angiography in glaucoma: a mini-review. F1000Res. 2017;6:1686.","journal-title":"F1000Res"},{"key":"1707_CR17","unstructured":"Weinreb RN, Garway-Heath DF, Leung C, Medeiros FA, Liebmann J. Diagnosis of primary open angle glaucoma: world glaucoma association consensus series 10: Kugler Publications; 2017. ISB: 978-90-6299-262-1. https:\/\/www.kuglerpublications.com\/index.php?p=322&page=publication."},{"issue":"4","key":"1707_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012;7(4):e34823.","journal-title":"PLoS One"},{"issue":"318","key":"1707_CR19","first-page":"626","volume":"62","author":"Z Sidak","year":"1967","unstructured":"Sidak Z. Rectangular confidence regions for the means of multivariate Normal distributions. J Am Stat Assoc. 1967;62(318):626\u201333.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"1707_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.exer.2003.12.007","volume":"78","author":"Y Takagi","year":"2004","unstructured":"Takagi Y, Nakajima T, Shimazaki A, Kageyama M, Matsugi T, Matsumura Y, et al. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res. 2004;78(4):767\u201376.","journal-title":"Exp Eye Res"},{"issue":"6","key":"1707_CR21","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.04-1527","volume":"46","author":"T Ota","year":"2005","unstructured":"Ota T, Murata H, Sugimoto E, Aihara M, Araie M. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Invest Ophthalmol Vis Sci. 2005;46(6):2006\u201311.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1707_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12325-016-0448-9","volume":"34","author":"AG Konstas","year":"2017","unstructured":"Konstas AG, Boboridis KG, Kapis P, Marinopoulos K, Voudouragkaki IC, Panayiotou D, et al. 24-hour efficacy and ocular surface health with preservative-free Tafluprost alone and in conjunction with preservative-free Dorzolamide\/Timolol fixed combination in open-angle glaucoma patients insufficiently controlled with preserved Latanoprost Monotherapy. Adv Ther. 2017;34(1):221\u201335.","journal-title":"Adv Ther"},{"issue":"1","key":"1707_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/jop.2009.0066","volume":"26","author":"CE Traverso","year":"2010","unstructured":"Traverso CE, Ropo A, Papadia M, Uusitalo H. A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of Tafluprost compared with latanoprost. J Ocul Pharmacol Ther. 2010;26(1):97\u2013104.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"1707_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/jop.2006.0061","volume":"23","author":"A Sutton","year":"2007","unstructured":"Sutton A, Gilvarry A, Ropo A. A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males. J Ocul Pharmacol Ther. 2007;23(4):359\u201365.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"1707_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.exer.2008.06.005","volume":"87","author":"Y Dong","year":"2008","unstructured":"Dong Y, Watabe H, Su G, Ishikawa H, Sato N, Yoshitomi T. Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries. Exp Eye Res. 2008;87(3):251\u20136.","journal-title":"Exp Eye Res"},{"issue":"5","key":"1707_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/IJG.0b013e318237c8b3","volume":"22","author":"S Tsuda","year":"2013","unstructured":"Tsuda S, Yokoyama Y, Chiba N, Aizawa N, Shiga Y, Yasuda M, et al. Effect of topical tafluprost on optic nerve head blood flow in patients with myopic disc type. J Glaucoma. 2013;22(5):398\u2013403.","journal-title":"J Glaucoma"},{"issue":"4","key":"1707_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21(4):359\u201393.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1707_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/01.icu.0000156134.38495.0b","volume":"16","author":"MC Grieshaber","year":"2005","unstructured":"Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005;16(2):79\u201383.","journal-title":"Curr Opin Ophthalmol"},{"issue":"41","key":"1707_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004907","volume":"95","author":"A Wylegala","year":"2016","unstructured":"Wylegala A, Teper S, Dobrowolski D, Wylegala E. Optical coherence angiography: a review. Medicine (Baltimore). 2016;95(41):e4907.","journal-title":"Medicine (Baltimore)"},{"key":"1707_CR30","doi-asserted-by":"crossref","first-page":"6956717","DOI":"10.1155\/2016\/6956717","volume":"2016","author":"PM Leveque","year":"2016","unstructured":"Leveque PM, Zeboulon P, Brasnu E, Baudouin C, Labbe A. Optic disc vascularization in glaucoma: value of spectral-domain optical coherence tomography angiography. J Ophthalmol. 2016;2016:6956717.","journal-title":"J Ophthalmol"},{"issue":"9","key":"1707_CR31","doi-asserted-by":"publisher","first-page":"OCT451","DOI":"10.1167\/iovs.15-18944","volume":"57","author":"A Yarmohammadi","year":"2016","unstructured":"Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Manalastas PI, Fatehee N, et al. Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes. Invest Ophthalmol Vis Sci. 2016;57(9):OCT451\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1707_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/IJG.0000000000000649","volume":"26","author":"T Mansoori","year":"2017","unstructured":"Mansoori T, Sivaswamy J, Gamalapati JS, Balakrishna N. Radial Peripapillary capillary density measurement using optical coherence tomography angiography in early glaucoma. J Glaucoma. 2017;26(5):438\u201343.","journal-title":"J Glaucoma"},{"issue":"12","key":"1707_CR33","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.ophtha.2016.08.041","volume":"123","author":"A Yarmohammadi","year":"2016","unstructured":"Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Yousefi S, Saunders LJ, et al. Relationship between optical coherence tomography angiography vessel density and severity of visual field loss in glaucoma. Ophthalmology. 2016;123(12):2498\u2013508.","journal-title":"Ophthalmology."},{"issue":"10","key":"1707_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205773","volume":"13","author":"A Rabiolo","year":"2018","unstructured":"Rabiolo A, Gelormini F, Sacconi R, Cicinelli MV, Triolo G, Bettin P, et al. Comparison of methods to quantify macular and peripapillary vessel density in optical coherence tomography angiography. PLoS One. 2018;13(10):e0205773.","journal-title":"PLoS One"},{"issue":"10","key":"1707_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/IJG.0000000000000768","volume":"26","author":"PIC Manalastas","year":"2017","unstructured":"Manalastas PIC, Zangwill LM, Saunders LJ, Mansouri K, Belghith A, Suh MH, et al. Reproducibility of optical coherence tomography angiography macular and optic nerve head vascular density in glaucoma and healthy eyes. J Glaucoma. 2017;26(10):851\u20139.","journal-title":"J Glaucoma"},{"issue":"9","key":"1707_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jamaophthalmol.2015.2225","volume":"133","author":"L Liu","year":"2015","unstructured":"Liu L, Jia Y, Takusagawa HL, Pechauer AD, Edmunds B, Lombardi L, et al. Optical coherence tomography angiography of the Peripapillary retina in glaucoma. JAMA Ophthalmol. 2015;133(9):1045\u201352.","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"1707_CR37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.ophtha.2014.01.021","volume":"121","author":"Y Jia","year":"2014","unstructured":"Jia Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014;121(7):1322\u201332.","journal-title":"Ophthalmology."},{"issue":"3","key":"1707_CR38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00417-017-3865-9","volume":"256","author":"M Alnawaiseh","year":"2018","unstructured":"Alnawaiseh M, Lahme L, Muller V, Rosentreter A, Eter N. Correlation of flow density, as measured using optical coherence tomography angiography, with structural and functional parameters in glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2018;256(3):589\u201397.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"1707_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/IJG.0000000000000964","volume":"27","author":"RC Penteado","year":"2018","unstructured":"Penteado RC, Zangwill LM, Daga FB, Saunders LJ, Manalastas PIC, Shoji T, et al. Optical coherence tomography angiography macular vascular density measurements and the central 10-2 visual field in glaucoma. J Glaucoma. 2018;27(6):481\u20139.","journal-title":"J Glaucoma"},{"issue":"8","key":"1707_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamaophthalmol.2018.1627","volume":"136","author":"KH Wan","year":"2018","unstructured":"Wan KH, Lam AKN, Leung CK. Optical coherence tomography angiography compared with optical coherence tomography macular measurements for detection of glaucoma. JAMA Ophthalmol. 2018;136(8):866\u201374.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1707_CR41","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1111\/aos.13914","volume":"97","author":"R Kromer","year":"2019","unstructured":"Kromer R, Glusa P, Framme C, Pielen A, Junker B. Optical coherence tomography angiography analysis of macular flow density in glaucoma. Acta Ophthalmol. 2019;97(2):e199\u2013206.","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"1707_CR42","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.ophtha.2018.05.006","volume":"125","author":"S Moghimi","year":"2018","unstructured":"Moghimi S, Zangwill LM, Penteado RC, Hasenstab K, Ghahari E, Hou H, et al. Macular and optic nerve head vessel density and progressive retinal nerve fiber layer loss in glaucoma. Ophthalmology. 2018;125(11):1720\u20138.","journal-title":"Ophthalmology."},{"key":"1707_CR43","first-page":"8909714","volume":"2018","author":"JH In","year":"2018","unstructured":"In JH, Lee SY, Cho SH, Hong YJ. Peripapillary vessel density reversal after trabeculectomy in glaucoma. J Ophthalmol. 2018;2018:8909714.","journal-title":"J Ophthalmol"},{"key":"1707_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.preteyeres.2017.07.002","volume":"60","author":"AH Kashani","year":"2017","unstructured":"Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66\u2013100.","journal-title":"Prog Retin Eye Res"},{"key":"1707_CR45","doi-asserted-by":"crossref","first-page":"2890357","DOI":"10.1155\/2018\/2890357","volume":"2018","author":"M Alnawaiseh","year":"2018","unstructured":"Alnawaiseh M, Muller V, Lahme L, Merte RL, Eter N. Changes in flow density measured using optical coherence tomography angiography after iStent insertion in combination with phacoemulsification in patients with open-angle glaucoma. J Ophthalmol. 2018;2018:2890357.","journal-title":"J Ophthalmol"},{"issue":"1","key":"1707_CR46","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1097\/IJG.0000000000000527","volume":"26","author":"G Hollo","year":"2017","unstructured":"Hollo G. Influence of large intraocular pressure reduction on Peripapillary OCT vessel density in ocular hypertensive and glaucoma eyes. J Glaucoma. 2017;26(1):e7\u2013e10.","journal-title":"J Glaucoma"},{"issue":"4","key":"1707_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00417-019-04553-2","volume":"258","author":"VC Brucher","year":"2020","unstructured":"Brucher VC, Storp JJ, Eter N, Alnawaiseh M. Optical coherence tomography angiography-derived flow density: a review of the influencing factors. Graefes Arch Clin Exp Ophthalmol. 2020;258(4):701\u201310.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"1707_CR48","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/bjophthalmol-2016-309642","volume":"101","author":"LS Geyman","year":"2017","unstructured":"Geyman LS, Garg RA, Suwan Y, Trivedi V, Krawitz BD, Mo S, et al. Peripapillary perfused capillary density in primary open-angle glaucoma across disease stage: an optical coherence tomography angiography study. Br J Ophthalmol. 2017;101(9):1261\u20138.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01707-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01707-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01707-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:43:04Z","timestamp":1618368184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01707-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01707-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study design was approved by the appropriate ethics review board. Written informed consent was obtained from each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained by each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No further competing interests statement on behalf of all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"444"}}